Michael W. Kattan, Ph.D.
Quantitative Health Sciences /JJN3
Professor of Medicine, Epidemiology and Biostatistics, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 2006-present
Dr. Kattan's research is primarily focused on the development, validation, and use of prediction models. Most of these models are available online, and designed for physician use, at http://rcalc.ccf.org/. He is also interested in quality of life assessment to support medical decision making (such as utility assessment), decision analysis, cost-effectiveness analysis, and comparative effectiveness. His journal publications are listed here. His Google Scholar page is here, and his ResearchGate page is here.
Kattan MW, Gerds TA. Comparison of Two Ordinal Prediction Models: A Cancer Staging System Example. Clin Trials. 2015.
Kattan MW, Yu C, Stephenson AJ, Sartor O, Tombal B. Clinicians versus nomogram: predicting future 99mTc-bone scan positivity in patients with rising prostate-specific antigen following radical prostatectomy for prostate cancer. Urology. 2013 May;81(5):956-961.
Kattan MW, Gerds TA. Stages of prediction model comparison. Eur Urol. 2012 Oct;62(4):597-599.
Kattan MW. Factors affecting the accuracy of prediction models limit the comparison of rival prediction models when applied to separate data sets. Eur Urol. 2011 April;59(4):566-567.
Kattan MW. Doc, what are my chances? A conversation about prognostic uncertainty. Eur Urol. 2011 Feb;59(2):224.
Kattan MW. Comparative effectiveness: a table of expected benefits and harms. Med Decis Making. 2009 Nov-Dec;29(6):NP3-NP5.